BMO Capital Markets downgraded Chemours from Outperform to Underperform and set a new price target of $19.00 from $45.00 previously
Get the next $CC alert in real time by email
Chat with this insight
Save time and jump to the most important pieces.
Recent Analyst Ratings for $CC
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/27/2025 | $19.00 | Neutral → Outperform | Mizuho |
| 1/28/2025 | $27.00 | Buy | Truist |
| 7/9/2024 | $28.00 → $30.00 | Neutral → Buy | UBS |
| 6/7/2024 | $25.00 | Neutral | Mizuho |
| 4/9/2024 | $19.00 → $34.00 | Underperform → Outperform | BMO Capital Markets |
| 3/5/2024 | $37.00 → $21.00 | Buy → Neutral | UBS |
| 2/29/2024 | $45.00 → $19.00 | Outperform → Underperform | BMO Capital Markets |
| 12/1/2023 | $28.00 → $40.00 | Sector Perform → Outperform | RBC Capital Mkts |
Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2025 financial results after market on Tuesday, May 6, 2025. The Company expects to hold its conference call to discuss its first quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, May 7, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC) is a glo
Gabelli Funds to Host 16th Annual Specialty Chemicals Symposium Thursday, March 20, 2025
GREENWICH, Conn., March 18, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds is hosting its 16th Annual Specialty Chemicals Symposium taking place at The Harvard Club in New York, NY on Thursday, March 20, 2025. The symposium will draw a variety of companies, with a focus on pricing power, margin recovery, interest rates, inventory stabilization, global trade policy, demand trends, and the M&A environment. Attendees will also have the opportunity to meet with managements in a one-on-one setting. Agenda: 8:50amOpening Remarks Rosemarie Morbelli, CFA Gabelli Funds Wayne Pinsent, CFA Gabelli Funds 9:00Arq, Inc. (NASDAQ:ARQ)* Bob Rasmus, President & CEO 9:30BASF Corporation
Energy Fuels and Chemours Forming Strategic Alliance to Create a Domestic Supply Chain of Critical Minerals for the United States
DENVER, March 18, 2025 /PRNewswire/ - Energy Fuels Inc. (NYSE:UUUU) (TSX:EFR) and The Chemours Company (NYSE:CC) today announced they are forming a strategic alliance to expand the companies' existing relationship to enhance U.S. domestic rare earth and critical mineral supply chains to meet increasing demand. The alliance will capitalize on the complementary geographic and operational synergies of both organizations. Energy Fuels, a leading U.S. producer of rare earth elements, is currently developing new heavy mineral sands projects in Madagascar, Brazil, and Australia, expe
Chemours upgraded by Mizuho with a new price target
Mizuho upgraded Chemours from Neutral to Outperform and set a new price target of $19.00
Truist initiated coverage on Chemours with a new price target
Truist initiated coverage of Chemours with a rating of Buy and set a new price target of $27.00
Chemours upgraded by UBS with a new price target
UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously
Director Cowan Alister was granted 14,096 shares, increasing direct ownership by 65% to 35,831 units (SEC Form 4)
4 - Chemours Co (0001627223) (Issuer)
Director Farrell Dawn L was granted 14,096 shares, increasing direct ownership by 17% to 97,636 units (SEC Form 4)
4 - Chemours Co (0001627223) (Issuer)
Director Fletcher Pamela was granted 14,096 shares, increasing direct ownership by 135% to 24,565 units (SEC Form 4)
4 - Chemours Co (0001627223) (Issuer)
Chemours Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
8-K - Chemours Co (0001627223) (Filer)
SEC Form DEFA14A filed by Chemours Company
DEFA14A - Chemours Co (0001627223) (Filer)
SEC Form DEFA14A filed by Chemours Company
DEFA14A - Chemours Co (0001627223) (Filer)
DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600
NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P
Chemours Appoints Leslie M. Turner to its Board of Directors
Former Hershey and Coca-Cola Executive adds extensive legal, governance, and policy expertise to Chemours' Board of Directors The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Leslie M. Turner to its Board of Directors, effective February 19, 2025. The Company also announced the date for its 2025 Annual Shareholders Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250211667601/en/Chemours appoints Leslie M. Turner to its Board
Chemours Announces Damián Gumpel as President of Titanium Technologies and Diane Picho as Chief Enterprise Enablement Officer
The Chemours Company (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, announced the appointment of Damián Gumpel as President of Chemours' Titanium Technologies (TT) business segment, effective March 3, 2025. Diane Iuliano Picho, who has served as Interim TT Business President since March 2024 has been appointed Chief Enterprise Enablement Officer, effective March 3, 2025. Both will report to Chemours President and CEO, Denise Dignam and serve on the Chemours Executive Team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho
Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2025 financial results after market on Tuesday, May 6, 2025. The Company expects to hold its conference call to discuss its first quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, May 7, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC) is a glo
Chemours Announces First Quarter Dividend
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the first quarter of 2025. The dividend will be paid on March 14, 2025, to stockholders of record as of the close of business on February 28, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solut
Chemours Announces Dates for Fourth Quarter 2024 Earnings Release and Webcast Conference Call
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its fourth quarter 2024 financial results before market on Tuesday, February 18, 2025. The Company expects to hold its conference call to discuss its fourth quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Tuesday, February 18, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (
Amendment: SEC Form SC 13G/A filed by Chemours Company
SC 13G/A - Chemours Co (0001627223) (Subject)
SEC Form SC 13G/A filed by Chemours Company (Amendment)
SC 13G/A - Chemours Co (0001627223) (Subject)
SEC Form SC 13G/A filed by Chemours Company (Amendment)
SC 13G/A - Chemours Co (0001627223) (Subject)